logo-loader
viewZacks Small-Cap Research

Zacks Small-Cap Research: combination therapies taking over as next generation in immuno-oncology

Zacks Small-Cap Research Senior Biotechnology Analyst John Vandermosten sat down with Proactive at the Biotech Showcase 2020 in San Francisco. Vandermosten explained how combination therapies are taking over as the next generation in immuno-oncology.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Castillo Copper's Ged Hall updates on key assets and progress on London dual...

Ged Hall works with London stockbroker SI Capital and is also a non-exec director at Castillo Copper Ltd's (ASX:CCZ). He discusses how the two came to work together as well as updates on what Castillo's doing as far as the Mt Oxide project in Queensland, Australia. 

1 day, 23 hours ago

2 min read